Cargando…
Biotechnological challenges: The scope of genome editing
CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human e...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brazilian Society of Assisted Reproduction
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863103/ https://www.ncbi.nlm.nih.gov/pubmed/32598833 http://dx.doi.org/10.5935/1518-0557.20200038 |
_version_ | 1783647437019152384 |
---|---|
author | Lima, Natacha Salomé Martínez, A Gustavo |
author_facet | Lima, Natacha Salomé Martínez, A Gustavo |
author_sort | Lima, Natacha Salomé |
collection | PubMed |
description | CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debates and interdisciplinary discussions. This brings multiple challenges for both scientists and those who must regulate the use of these techniques. |
format | Online Article Text |
id | pubmed-7863103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Brazilian Society of Assisted Reproduction |
record_format | MEDLINE/PubMed |
spelling | pubmed-78631032021-02-10 Biotechnological challenges: The scope of genome editing Lima, Natacha Salomé Martínez, A Gustavo JBRA Assist Reprod Update Article CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debates and interdisciplinary discussions. This brings multiple challenges for both scientists and those who must regulate the use of these techniques. Brazilian Society of Assisted Reproduction 2021 /pmc/articles/PMC7863103/ /pubmed/32598833 http://dx.doi.org/10.5935/1518-0557.20200038 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Update Article Lima, Natacha Salomé Martínez, A Gustavo Biotechnological challenges: The scope of genome editing |
title | Biotechnological challenges: The scope of genome editing |
title_full | Biotechnological challenges: The scope of genome editing |
title_fullStr | Biotechnological challenges: The scope of genome editing |
title_full_unstemmed | Biotechnological challenges: The scope of genome editing |
title_short | Biotechnological challenges: The scope of genome editing |
title_sort | biotechnological challenges: the scope of genome editing |
topic | Update Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863103/ https://www.ncbi.nlm.nih.gov/pubmed/32598833 http://dx.doi.org/10.5935/1518-0557.20200038 |
work_keys_str_mv | AT limanatachasalome biotechnologicalchallengesthescopeofgenomeediting AT martinezagustavo biotechnologicalchallengesthescopeofgenomeediting |